Krendyukov, A., Kneisel, N., Zhu, J., Merz, C., Richards, D., Gieffers, C., . . . Mitchell, T. (2020). The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model. Elsevier.
Lua i Stíl Chicago (17ú heag.)Krendyukov, A., N. Kneisel, J. Zhu, C. Merz, D. Richards, C. Gieffers, B. Van Den Eynde, agus T. Mitchell. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. Elsevier, 2020.
Lua MLA (9ú heag.)Krendyukov, A., et al. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. Elsevier, 2020.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.